Skip to content
OpenCapital
Get started

Idexx Laboratories IDXX EPS (Diluted)

EPS (Diluted) at other companies

Travel + Leisure logo
Travel + LeisureTNL
$1.22+14.0%
Warrior Met Coal logo
Warrior Met CoalHCC
$1.37+956%
Cabot Corporation logo
Cabot CorporationCBT
$1.27-24.9%
Unifirst logo
UnifirstUNF
$1.13-13.7%
Main Street Capital logo
Main Street CapitalMAIN
$0.93-4.1%
MYR Group logo
MYR GroupMYRG
$2.99+106%

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$43.78B+3.9%
Enterprise value$44.15B+3.4%
P/E40×-7.1×
P/S9.9×-0.9×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's EPS (diluted)?
Idexx Laboratories (IDXX) reported EPS (diluted) of $3.47 in Q1 2026.
How has Idexx Laboratories's EPS (diluted) changed year-over-year?
Idexx Laboratories's EPS (diluted) increased by 17.2% year-over-year, from $2.96 to $3.47.
What is the long-term trend for Idexx Laboratories's EPS (diluted)?
Over 4 years (2021 to 2025), Idexx Laboratories's EPS (diluted) has grown at a 11.0% compound annual growth rate (CAGR), from $8.61 to $13.08.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.